Dr. Fatheya AlAwadi

Dr. Fatheya AlAwadi is a prominent UAE Consultant Endocrinologist and Diabetes specialist based at Dubai Hospital, Dubai Health. She is currently Head of the Endocrine Section/Department at Dubai Hospital and serves as President of the Emirates Diabetes & Endocrine Society (EDES).

Professional Background

Dr. AlAwadi completed her postgraduate studies at the University of Glasgow, UK, before returning to the UAE and continuing her medical career with the former Dubai Department of Health and Medical Services (DOHMS), now Dubai Health.

Her professional qualifications include MSc in Diabetes and Endocrinology, FRCP and FACE. She has developed a long career in clinical endocrinology, diabetes care, medical education and research.

Current & Previous Positions

• Consultant Endocrinologist, Dubai Hospital
• Head of the Endocrine Section/Department, Dubai Hospital
• President, Emirates Diabetes & Endocrine Society (EDES)
• Chairperson, Diabetes Combat and Control Committee, Dubai Health
• Member, National Diabetes Committee, MOHAP
• Clinical Professor of Medicine, Mohammed Bin Rashid University (MBRU)
• Adjunct Clinical Associate Professor, University of Sharjah
• Federation Lead for Royal College PACES in Dubai and Sharjah
• Chief Editor, Dubai Diabetes & Endocrine Journal (DDEJ)

Major Clinical Achievement

One of Dr. AlAwadi's notable contributions to diabetes care in Dubai was founding Dubai's first diabetic One-Stop Shop Clinic. The service brought together specialized clinics including diabetic nephrology, diabetic antenatal care and thyroid services, creating a more integrated approach to diabetes and endocrine care.

Research & Academic Contributions

Dr. AlAwadi has been extensively involved in diabetes and endocrinology research, with more than 80 peer-reviewed publications according to her current conference biography.

Her research has covered:

• Diabetes management
• Ramadan fasting and diabetes
• Continuous glucose monitoring
• Diabetes complications
• Obesity and metabolic disease
• Cardiovascular risk in diabetes
• Gestational diabetes
• Osteoporosis
• Public-health patterns of diabetes in Dubai

She was a co-author of influential research investigating how Ramadan-focused diabetes education, glucose monitoring and treatment adjustment can improve the safety of fasting in high-risk patients with diabetes.

She also contributed to research examining glycemic control among patients with diabetes across Dubai's primary and tertiary government healthcare sectors, using a five-year dataset.

Research Grant

In 2016, Dr. AlAwadi and Dr. Mohammed Hassanein received an Al Jalila Foundation Research Grant for a diabetes research project titled "Reducing diabetes complications in high-risk groups during Ramadan." The project focused on identifying high-risk diabetic patients who fast during Ramadan and developing strategies to reduce complications.

International & Regional Leadership

Dr. AlAwadi has played an important role in promoting endocrinology and diabetes education in the UAE and the wider region. Under her leadership, the Emirates Diabetes & Endocrine Society has developed educational and scientific activities and helped attract major international endocrine meetings to Dubai. She has also served as a member of the International Society of Endocrinology Executive Board.

She continues to participate as faculty and scientific leadership in major regional meetings, including the 16th Emirates Diabetes & Endocrine Congress 2026.